Primary Disorders of Metabolism and Disturbed Fetal Brain Development

Clinics in Perinatology

Volumn 36, Issue 3, 2009, Pages 621-638

  Prasad, Asuri N ^a   Malinger, Gustavo ^b   Lerman Sagie, Tally ^b  

^a CHILDREN S HOSPITAL OF WESTERN ONTARIO   (Canada)

^b WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Cerebral dysmorphogenesis; Fetal brain; Inborn errors of metabolism; Neurosonography; Prenatal diagnosis; Ultrasound

Indexed keywords

BRAIN DEVELOPMENT; BRAIN MALFORMATION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CEREBELLUM DISEASE; CORPUS CALLOSUM AGENESIS; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ECHOGRAPHY; ENERGY METABOLISM; GENETIC COUNSELING; HOLOPROSENCEPHALY; HUMAN; INBORN ERROR OF METABOLISM; MORPHOLOGY; NERVE CELL; NERVE CELL PLASTICITY; NEURAL TUBE DEFECT; NEUROTOXICITY; NEURULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL DEFICIENCY; ORGANOGENESIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

BRAIN; BRAIN DISEASES, METABOLIC, INBORN; FEMALE; HUMANS; NERVOUS SYSTEM MALFORMATIONS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 69549122629     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2009.06.004     Document Type: Review

References (102)

1. Volpe J.J. Overview: normal and abnormal human brain development. Ment Retard Dev Disabil Res Rev 6 1 (2000) 1-5
2. O'Rahilly R., and Müller F. The embryonic human brainan atlas of developmental stages. 3rd edition (2006), Wiley-Liss, Hoboken (NJ)
3. Graf W. Cerebral dysgenesis secondary to metabolic diseases in fetal life. In: Aminoff MJ, Boller F, Swaab DF, editors. Handbook of clinical neurology. Amsterdam: Handb Clin Neurol 2007;87:459-476.
4. Bamforth F., Bamforth S., Poskitt K., et al. Abnormalities of corpus callosum in patients with inherited metabolic diseases [letter]. Lancet 2 8608 (1988) 451
5. Nissenkorn A., Michelson M., Ben-Zeev B., et al. Inborn errors of metabolism: a cause of abnormal brain development. Neurology 56 10 (2001) 1265-1272
6. Prasad A., Rupar C., Prasad C., et al. Cellular bioenergetics and cerebral dysmorphogenesis: lessons from Amish microcephaly. Neuropediatrics 37 S1 (2006). http://www.thieme-connect.com/ejournals/abstract/neuropediatrics/doi/10. 1055/s-2006-945606 Accessed June 28, 2009
7. Dobyns W.B. Agenesis of the corpus callosum and gyral malformations are frequent manifestations of nonketotic hyperglycinemia. Neurology 39 6 (1989) 817-820
8. Zhang X., Vincent A.S., Halliwell B., et al. A mechanism of sulfite neurotoxicity: direct inhibition of glutamate dehydrogenase. J Biol Chem 279 41 (2004) 43035-43045
9. Schiaffino M.C., Fantasia A.R., Minniti G., et al. Isolated sulphite oxidase deficiency: clinical and biochemical features in an Italian patient. J Inherit Metab Dis 27 1 (2004) 101-102
10. Rupar C.A., Gillett J., Gordon B.A., et al. Isolated sulfite oxidase deficiency. Neuropediatrics 27 6 (1996) 299-304
11. Roth A., Nogues C., Monnet J.P., et al. Anatomo-pathological findings in a case of combined deficiency of sulphite oxidase and xanthine oxidase with a defect of molybdenum cofactor. Virchows Arch A Pathol Anat Histopathol 405 3 (1985) 379-386
12. van Straaten H.L., van Tintelen J.P., Trijbels J.M., et al. Neonatal lactic acidosis, complex I/IV deficiency, and fetal cerebral disruption. Neuropediatrics 36 3 (2005) 193-199
13. Chow C.W., and Thorburn D.R. Morphological correlates of mitochondrial dysfunction in children. Hum Reprod 15 Suppl 2 (2000) 68-78
14. de Koning T.J., de Vries L.S., Groenendaal F., et al. Pontocerebellar hypoplasia associated with respiratory-chain defects. Neuropediatrics 30 2 (1999) 93-95
15. Sarnat H.B., and Marin-Garcia J. Pathology of mitochondrial encephalomyopathies. Can J Neurol Sci 32 2 (2005) 152-166
16. Shevell M.I., Matthews P.M., Scriver C.R., et al. Cerebral dysgenesis and lactic acidemia: an MRI/MRS phenotype associated with pyruvate dehydrogenase deficiency. Pediatr Neurol 11 3 (1994) 224-229
17. Porter F.D. Human malformation syndromes due to inborn errors of cholesterol synthesis. Curr Opin Pediatr 15 6 (2003) 607-613
18. Ingham P.W. Hedgehog signaling: a tale of two lipids. Science 294 5548 (2001) 1879-1881
19. Ahlgren S., and Bronner-Fraser M. Recycling signaling molecules during development. Nat Neurosci 5 2 (2002) 87-88
20. Caruso P.A., Poussaint T.Y., Tzika A.A., et al. MRI and 1H MRS findings in Smith-Lemli-Opitz syndrome. Neuroradiology 46 1 (2004) 3-14
21. Johnson J.A., Aughton D.J., Comstock C.H., et al. Prenatal diagnosis of Smith-Lemli-Opitz syndrome, type II. Am J Med Genet 49 2 (1994) 240-243
22. Lanoue L., Dehart D.B., Hinsdale M.E., et al. Limb, genital, CNS, and facial malformations result from gene/environment-induced cholesterol deficiency: further evidence for a link to sonic hedgehog. Am J Med Genet 73 1 (1997) 24-31
23. Guirland C., Suzuki S., Kojima M., et al. Lipid rafts mediate chemotropic guidance of nerve growth cones. Neuron 42 1 (2004) 51-62
24. Simons K., and Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest 110 5 (2002) 597-603
25. Baumgart E., Vanhorebeek I., Grabenbauer M., et al. Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am J Pathol 159 4 (2001) 1477-1494
26. Kovacs W.J., Olivier L.M., and Krisans S.K. Central role of peroxisomes in isoprenoid biosynthesis. Prog Lipid Res 41 5 (2002) 369-391
27. Faust P.L., Banka D., Siriratsivawong R., et al. Peroxisome biogenesis disorders: the role of peroxisomes and metabolic dysfunction in developing brain. J Inherit Metab Dis 28 3 (2005) 369-383
28. Stahnisch F.W., and Nitsch R. Santiago Ramon y Cajal's concept of neuronal plasticity: the ambiguity lives on. Trends Neurosci 25 11 (2002) 589-591
29. Johnston M.V., Nishimura A., Harum K., et al. Sculpting the developing brain. Adv Pediatr 48 (2001) 1-38
30. Johnston M.V. Injury and plasticity in the developing brain. Exp Neurol 184 Suppl 1 (2003) S37-S41
31. Pooh R.K., and Pooh K. Transvaginal 3D and Doppler ultrasonography of the fetal brain. Semin Perinatol 25 1 (2001) 38-43
32. Pooh R.K., Pooh K., Nakagawa Y., et al. Clinical application of three-dimensional ultrasound in fetal brain assessment. Croat Med J 41 3 (2000) 245-251
33. Timor-Tritsch I.E., Monteagudo A., and Mayberry P. Three-dimensional ultrasound evaluation of the fetal brain: the three horn view. Ultrasound Obstet Gynecol 16 4 (2000) 302-306
34. Monteagudo A., and Timor-Tritsch I.E. Normal sonographic development of the central nervous system from the second trimester onwards using 2D, 3D and transvaginal sonography. Prenat Diagn 29 (2009) 326-339
35. Monteagudo A., Timor-Tritsch I.E., and Mayberry P. Three-dimensional transvaginal neurosonography of the fetal brain: navigating in the volume scan. Ultrasound Obstet Gynecol 16 4 (2000) 307-313
36. Pilu G., Segata M., Ghi T., et al. Diagnosis of midline anomalies of the fetal brain with the three-dimensional median view. Ultrasound Obstet Gynecol 27 5 (2006) 522-529
37. Israels S., Haworth J.C., Dunn H.G., et al. Lactic acidosis in childhood. Adv Pediatr 22 (1976) 267-303
38. Aleck K.A., Kaplan A.M., Sherwood W.G., et al. In utero central nervous system damage in pyruvate dehydrogenase deficiency. Arch Neurol 45 9 (1988) 987-989
39. de Meirleir L.J., Lissens W., Vamos E., et al. Pyruvate dehydrogenase deficiency due to a mutation of the E1 alpha subunit. J Inherit Metab Dis 14 3 (1991) 301-304
40. De Meirleir L., Lissens W., Vamos E., et al. Pyruvate dehydrogenase (PDH) deficiency caused by a 21-base pair insertion mutation in the E1 alpha subunit. Hum Genet 88 6 (1992) 649-652
41. Chun K., MacKay N., Petrova-Benedict R., et al. Mutations in the X-linked E1 alpha subunit of pyruvate dehydrogenase leading to deficiency of the pyruvate dehydrogenase complex. Hum Mol Genet 2 4 (1993) 449-454
42. Hansen L.L., Brown G.K., Brown R.M., et al. Pyruvate dehydrogenase deficiency caused by a 5 base pair duplication in the E1 alpha subunit. Hum Mol Genet 2 6 (1993) 805-807
43. Otero L.J., Brown R.M., and Brown G.K. Arginine 302 mutations in the pyruvate dehydrogenase E1alpha subunit gene: identification of further patients and in vitro demonstration of pathogenicity. Hum Mutat 12 2 (1998) 114-121
44. Chow C.W., Anderson R.M., and Kenny G.C. Neuropathology in cerebral lactic acidosis. Acta Neuropathol 74 4 (1987) 393-396
45. Zand D.J., Simon E.M., Pulitzer S.B., et al. In vivo pyruvate detected by MR spectroscopy in neonatal pyruvate dehydrogenase deficiency. AJNR Am J Neuroradiol 24 7 (2003) 1471-1474
46. Brown R.M., and Brown G.K. Prenatal diagnosis of pyruvate dehydrogenase E1 alpha subunit deficiency. Prenat Diagn 14 6 (1994) 435-441
47. Taylor M.R., Hurley J.B., Van Epps H.A., et al. A zebrafish model for pyruvate dehydrogenase deficiency: rescue of neurological dysfunction and embryonic lethality using a ketogenic diet. Proc Natl Acad Sci U S A 101 13 (2004) 4584-4589
48. Opitz J.M., Penchaszadeh V.B., Holt M.C., et al. Smith-Lemli-Opitz (RSH) syndrome bibliography. Am J Med Genet 28 3 (1987) 745-750
49. Penchaszadeh V.B. The nosology of the Smith-Lemli-Opitz syndrome. Am J Med Genet 28 3 (1987) 719-721
50. Porter F.D. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet 16 5 (2008) 535-541
51. Irons M., Elias E.R., Tint G.S., et al. Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in four patients and treatment in one patient. Am J Med Genet 50 4 (1994) 347-352
52. Goldenberg A., Wolf C., Chevy F., et al. Antenatal manifestations of Smith-Lemli-Opitz (RSH) syndrome: a retrospective survey of 30 cases. Am J Med Genet A 124 4 (2004) 423-426
53. Shinawi M., Szabo S., Popek E., et al. Recognition of Smith-Lemli-Opitz syndrome (RSH) in the fetus: utility of ultrasonography and biochemical analysis in pregnancies with low maternal serum estriol. Am J Med Genet A 138 1 (2005) 56-60
54. Battaile K.P., Maslen C.L., Wassif C.A., et al. A simple PCR-based assay allows detection of a common mutation, IVS8-1G→C, in DHCR7 in Smith-Lemli-Opitz syndrome. Genet Test 3 4 (1999) 361-363
55. Wassif C.A., Maslen C., Kachilele-Linjewile S., et al. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am J Hum Genet 63 1 (1998) 55-62
56. Nowaczyk M.J., Heshka T., Kratz L.E., et al. Difficult prenatal diagnosis in mild Smith-Lemli-Opitz syndrome. Am J Med Genet 95 4 (2000) 396-398
57. Goodman S.I., and Kohlhoff J.G. Glutaric aciduria: inherited deficiency of glutaryl-CoA dehydrogenase activity. Biochem Med 13 2 (1975) 138-140
58. Superti-Furga A., and Hoffmann G.F. Glutaric aciduria type 1 (glutaryl-CoA-dehydrogenase deficiency): advances and unanswered questions. Report from an international meeting. Eur J Pediatr 156 11 (1997) 821-828
59. Funk C.B., Prasad A.N., Frosk P., et al. Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain 128 Pt 4 (2005) 711-722
60. Forstner R., Hoffmann G.F., Gassner I., et al. Glutaric aciduria type I: ultrasonographic demonstration of early signs. Pediatr Radiol 29 2 (1999) 138-143
61. Lin S.K., Hsu S.G., Ho E.S., et al. Glutaric aciduria (type I): prenatal ultrasonographic findings. Ultrasound Obstet Gynecol 20 3 (2002) 305-307
62. Lin S.K., Hsu S.G., Ho E.S., et al. Novel mutation and prenatal sonographic findings of glutaric aciduria (type I) in two Taiwanese families. Prenat Diagn 22 8 (2002) 725-729
63. Busquets C., Coll M.J., Merinero B., et al. Prenatal molecular diagnosis of glutaric aciduria type I by direct mutation analysis. Prenat Diagn 20 9 (2000) 761-764
64. Baric I., Zschocke J., Christensen E., et al. Diagnosis and management of glutaric aciduria type I. J Inherit Metab Dis 21 4 (1998) 326-340
65. Jaeken J., and Carchon H. The carbohydrate-deficient glycoprotein syndromes: an overview. J Inherit Metab Dis 16 5 (1993) 813-820
66. Krasnewich D., and Gahl W.A. Carbohydrate-deficient glycoprotein syndrome. Adv Pediatr 44 (1997) 109-140
67. Matthijs G., Schollen E., and Van Schaftingen E. The prenatal diagnosis of congenital disorders of glycosylation (CDG). Prenat Diagn 24 2 (2004) 114-116
68. Jaeken J., Carchon H., and Stibler H. The carbohydrate-deficient glycoprotein syndromes: pre-Golgi and Golgi disorders?. Glycobiology 3 5 (1993) 423-428
69. Malinger G., Lev D., and Lerman-Sagie T. The fetal cerebellum: pitfalls in diagnosis and management. Prenat Diagn 29 4 (2009) 372-380
70. Hertz-Pannier L., Dechaux M., Sinico M., et al. Congenital disorders of glycosylation type I: a rare but new cause of hyperechoic kidneys in infants and children due to early microcystic changes. Pediatr Radiol 36 2 (2006) 108-114
71. Malhotra A., Pateman A., Chalmers R., et al. Prenatal cardiac ultrasound finding in congenital disorder of glycosylation type 1a. Fetal Diagn Ther 25 1 (2009) 54-57
72. van de Kamp J.M., Lefeber D.J., Ruijter G.J., et al. Congenital disorder of glycosylation type Ia presenting with hydrops fetalis. J Med Genet 44 4 (2007) 277-280
73. Rötig A., and Munnich A. Genetic features of mitochondrial respiratory chain disorders. J Am Soc Nephrol 14 12 (2003) 2995-3007
74. von Kleist-Retzow J.C., Cormier-Daire V., Viot G., et al. Antenatal manifestations of mitochondrial respiratory chain deficiency. J Pediatr 143 2 (2003) 208-212
75. Lincke C.R., van den Bogert C., Nijtmans L.G., et al. Cerebellar hypoplasia in respiratory chain dysfunction. Neuropediatrics 27 (1996) 216-218
76. Gire C., Girard N., Nicaise C., et al. Clinical features and neuroradiological findings of mitochondrial pathology in six neonates. Childs Nerv Syst 18 11 (2002) 621-628
77. Samson J.F., Barth P.G., de Vries J.I., et al. Familial mitochondrial encephalopathy with fetal ultrasonographic ventriculomegaly and intracerebral calcifications. Eur J Pediatr 153 7 (1994) 510-516
78. Malinger G., Kidron D., Schreiber L., et al. Prenatal diagnosis of malformations of cortical development by dedicated neurosonography. Ultrasound Obstet Gynecol 29 2 (2007) 178-191
79. Bouchet C., Steffann J., Corcos J., et al. Prenatal diagnosis of myopathy, encephalopathy, lactic acidosis, and stroke-like syndrome: contribution to understanding mitochondrial DNA segregation during human embryofetal development. J Med Genet 43 10 (2006) 788-792
80. Dahl H.H., Thorburn D.R., and White S.L. Towards reliable prenatal diagnosis of mtDNA point mutations: studies of nt8993mutations in oocytes, fetal tissues, children and adults. Hum Reprod 15 Suppl 2 (2000) 246-255
81. Minai L., Martinovic J., Chretien D., et al. Mitochondrial respiratory chain complex assembly and function during human fetal development. Mol Genet Metab 94 1 (2008) 120-126
82. Levy H.L., and Ghavami M. Maternal phenylketonuria: a metabolic teratogen. Teratology 53 3 (1996) 176-184
83. Levy H.L., Lobbregt D., Barnes P.D., et al. Maternal phenylketonuria: magnetic resonance imaging in offspring. J Pediatr 128 (1996) 770-775
84. Yik W.Y., Steinberg S.J., Moser A.B., et al. Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disorders. Hum Mutat 30 3 (2009) E467-E480
85. Volpe J.J., and Adams R.D. Cerebro-hepato-renal syndrome of Zellweger: an inherited disorder of neuronal migration. Acta Neuropathol 20 (1972) 175-198
86. Liu M.H., Bangaru B.S., Kidd J., et al. Neuropathological considerations in cerebro-hepato-renal syndrome (Zellweger's syndrome). Acta Neuropathol 34 (1976) 115-123
87. Gichrist K.W., Gilbert E.F., Goldfarb S., et al. Studies of malformation syndromes of man XIB: the cerebro-hepato-renal syndrome of Zellweger: comparative pathology. Eur J Pediatr 121 (1976) 99-118
88. Evrard P., Caviness V.S., Prats-Vinas J., et al. The mechanism of arrest of neuronal migration in the Zellweger malformation: an hypothesis based upon cytoarchitectonic analysis. Acta Neuropathol 41 (1978) 109-117
89. Sarnat H.B., Treven C.L., and Darwish H.S. Ependymal abnormalities in cerebro-hepato-renal disease of Zellweger. Brain Dev 15 (1993) 270-277
90. Van der Knaap M.S., and Valk J. The MR spectrum of peroxisomal disorders. Neuroradiology 33 (1991) 30-37
91. Barkovich A.J., and Peck W.W. MR of Zellweger syndrome. AJNR Am J Neuroradiol 18 (1997) 1163-1170
92. Torvik A., Torp S., Kase B.F., et al. Infantile Refsum disease: a generalized peroxisomal disorder. Case report with postmortem examination. J Neurol Sci 85 (1988) 39-53
93. Kyllerman M., Blomstrand S., Mansson J.E., et al. Central nervous system malformations and white matter changes in pseudo-neonatal adrenoleukodystrophy. Neuropediatrics 21 (1990) 199-201
94. Young S., Rabi Y., and Lodha A.K. Band heterotopia in Zellweger syndrome (cerebro-hepato-renal syndrome). Neurol India 55 1 (2007) 93
95. Goh S. Neuroimaging features in a neonate with rhizomelic chondrodysplasia punctata. Pediatr Neurol 37 5 (2007) 382-384
96. Mochel F., Grébille A.G., Benachi A., et al. Contribution of fetal MR imaging in the prenatal diagnosis of Zellweger syndrome. AJNR Am J Neuroradiol 27 2 (2006) 333-336
97. Steinberg S.J., Dodt G., Raymond G.V., et al. Peroxisome biogenesis disorders. Biochim Biophys Acta 1763 12 (2006) 1733-1748
98. Press G., Barshop B.A., Haas R.H., et al. Abnormalities of the brain in nonketotic hyperglycinemia: MR manifestations. AJNR Am J Neuroradiol 10 (1989) 315-321
99. Fletcher J.M., Bye A.M.E., Naynar V., et al. Non-ketotic hyperglycinemia presenting as pachygyria. J Inherit Metab Dis 18 (1995) 665-668
100. Alejo J., Rincon P., Vaquerizo J., et al. Transient non-ketotic hyperglycinemia: ultrasound, CT and MRI: case report. Neuroradiology 39 (1997) 658-660
101. Scher M.S., and Bergman I. Neurophysiological and anatomical correlations in neonatal nonketotic hyperglycinemia. Neuropediatrics 17 (1986) 137-143
102. Paupe A., Bidat L., Sonigo P., et al. Prenatal diagnosis of hypoplasia of the corpus callosum in association with non-ketotic hyperglycinemia. Ultrasound Obstet Gynecol 20 6 (2002) 616-619